Board of Directors

Executive Committee:

  • Gordon McCauley, President and CEO, adMare BioInnovations (Chair)
  • Roberto Bellini, President & CEO, Bellus Health (Vice Chair)
  • Oliver Technow, CEO, BioVectra Inc. (Treasurer)
  • Andrew Casey, President & CEO, BIOTECanada (Secretary)
  • Paul Petrelli, General Manager, Jazz Pharmaceuticals (Past Chair)


  • Norma Biln, CEO, Augurex
  • Neal Carter, President & Founder, Okanagan Specialty Fruits
  • Andy Haigh, President and CEO, Adapsyn Bioscience
  • Alok Kanti, General Manager, Bayer Canada
  • Melissa Koomey, Vice President & General Manager, Gilead Sciences Canada
  • A.J. (Sandy) Marshall, Chairman, Bioindustrial Innovation Canada
  • Jeffrey Miller, General Manager, Alnylam Pharmaceuticals Canada
  • John Norman, Partner, Gowling WLG (Canada) LLP
  • Tracey Ramsay, Vice President and General Manager, AbbVie Canada
  • Alan Reba, General Manager, Bristol-Myers Squibb
  • Sanj Singh, President & CEO, Temple Therapeutics B.V.
  • Jamie Stiff, Managing Director, Genesys Capital
  • Ali Tehrani, President and CEO, Zymeworks Inc.
  • Shermaine Tilley, Managing Partner, CTI Life Sciences Fund